Clinical Trial Update: Sequential Transarterial Chemoembolization (TACE), Stereotactic Body Radiation Therapy (SBRT), and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma Treated With Donafenib [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in China is testing sequential transarterial chemoembolization (TACE), stereotactic body radiation therapy (SBRT), and immune checkpoin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Donafenib (donafenib)

Snippet

Sponsor: Jinling Hospital, China | Conditions: Unresectable Hepatocellular Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING